Sex steroid hormones are major regulators of sexual characteristic among species. These hormones, however, are also produced in the brain. Steroidal hormone-mediated signalling via the corresponding hormone receptors can influence brain function at the cellular level and thus affect behaviour and higher brain functions. Altered steroid hormone signalling has been associated with psychiatric disorders, such as anxiety and depression.
gonadothropin-release hormones (GnRH) at the hypothalamus. GnRH induces the release of luteinising hormone (LH) and follicle-stimulating hormone (FSH) in the pituitary, which activate the secretion of steroidal sex hormones from the gonads ( Figure 1A ). Peripheral sex hormones are present in the plasma, where they are mainly bound to plasma proteins such as sex hormone binding globulin (SHBG) or corticosteroid binding globulin (CBG).
6 SHBG has high affinity for both oestrogens and androgens, whereas progesterone is bound by CBG.
These globulins protect steroid hormones against metabolic degradation and, consequently, the fraction of free steroid hormones in plasma is small. Yet, this small fraction of unbound steroid hormones can readily cross the blood-brain barrier by passive diffusion as a result of the lipophilic nature of steroids. However, there is also a significant contribution of de novo synthesised steroid hormones in the brain because the brain itself contains the enzymes needed for the synthesis of these steroids. 7 Sex hormones produced in the brain include 17β-oestradiol, testosterone and progesterone, along with other neuroactive steroids such as pregnenolone, dehydroepiandrosterone and allopregnanolone. 8 In recent decades, the specific receptors for sex steroid hormones were found to be expressed in the brain. 9 Currently, most information has been obtained from animal experiments, which cannot easily be translated to humans, as well as from post-mortem analysis of human brain tissue. 10, 11 In most studies, western blotting and in situ hybridisation have been used to quantify hormone receptors in the brain. 9, 12 Such techniques would not allow research on the biology of steroid hormones and their receptors in the living human brain. One approach with respect to non-invasively investigating sex hormone receptors in the brain is the use of positron emission tomography (PET) with radiolabelled receptor ligands. PET allows the quantification of functional parameters, such as receptor density and occupancy. 13 PET imaging of steroid receptors is already widely used in oncology to visualise receptor expression and receptor occupancy in hormone-sensitive tumours such as breast and prostate cancer. 14 By contrast, sex hormone receptor imaging in the brain is still in its infancy. 15 Sex steroid receptor imaging in neuroscience suffers from some additional hurdles, such as the low receptor expression in some brain regions 16 and a poor penetration of radioligands through the blood-brain barrier.
F I G U R E 1 Effects of sex steroids at both physiological and cellular levels. (A)
The regulatory processes for the synthesis of sex steroids by the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus regulates the production of luteinising hormone (LH) and follicle-stimulating hormone (FSH) via the release of gonadotrophin-releasing hormone (GnRH). Both LH and FSH stimulate the synthesis and release of oestrogens and progesterone from the ovaries in females, as well as testosterone from the testis in males. At the same time, these sex steroids can regulate the release of GnRH from the hypothalamus, as well as LH and FSH from the pituitary. (B) General scheme of sex steroid effects at cellular level. Sex hormones can bind to either cytoplasmatic receptors or membrane-associated receptors. When the molecules bind to membrane receptors, the receptor (coupled to G protein subunits complex: Gα, Gβ and Gγ) activates phospholipase C (PLC) to exert a rapid nongenomic responses via the second messengers inositol phosphate 3 (IP 3 +) and diacylglycerol (DAG). On the other hand, when they bind to cytoplasmatic receptors, the complex is translocated to the nucleus (with the help of different co-activators) to exert genomic effects In this review, we survey the available literature about the use of PET imaging in the field of neuroendocrinology, in which imaging data are directly or indirectly correlated with sex steroid hormone (receptor) levels. We discuss the role of sex steroids in brain function and behaviour, give an overview of the tracers that are currently available for PET imaging of hormone receptors and their applicability in brain research, and summarise the results of PET imaging of the downstream effects of sex steroids in the brain. Based on these data, we propose that PET is a promising technique for future translational research in this field.
| SEX STEROID HORMONES AND BRAIN FUNCTION
Oestrogens can exert their effects through either intracellular or membrane-associated oestrogen receptors (ERs); in particular, the intracellular receptors ERα and ERβ, and membrane-associated Gprotein regulator motifs. Upon binding of oestrogen to the ER, the ligand-receptor complex dimerises and migrates to the nucleus, where the dimer can bind to hormone response elements (HRE) in the pro- Oestrogen signalling can affect various aspects of brain function and behaviour. Most information about the relationship between oestrogens and brain disorders was obtained from studies in female animals or women demonstrating behavioural differences between the different stages of the menstrual cycle. There is ample evidence for a role of oestrogens in anxiety and depression, both from animals and humans. 18 Women are vulnerable to depression when the concentration of sex hormones changes markedly. This can lead to pre-menstrual dysphoric disorder, post-partum depression and perimenopausal or postmenopausal depression. 19 Oestrogens have antidepressant effects when they are administered either alone or in combination with antidepressants 20, 21 and, consequently, oestrogen replacement therapy can be used to prevent the development of depression in individuals who are at risk. 22 Oestrogens can also have neuroprotective effects. High levels of circulating oestrogens are associated with less ischaemia-induced brain injury. 23 A similar effect is also observed when high levels of endogenous oestrogens are synthesised in the brain.
24
Oestrogens were found to play a role in neuronal plasticity and spine synapse formation. 25, 26 
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Alterations of testosterone levels were associated with an increased risk of mood disorders and psychosis. 50 Anabolic abuse and hyper-or hypoandrogenism are related to mood changes 51 and the incidence of depression. 52 On the other hand, androgens can also have a neuroprotective role. Long-term exposure to androgens increases hippocampal neurogenesis and modulates the survival of new neurones.
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Androgens also play a role in synapse formation and they are capable of inducing the formation of spine synapses, 54 which appears to be mediated by NMDA activity. So far, only a few studies have measured the in vivo distribution of steroid receptor ligands in rodents, whereas imaging studies of the human brain are lacking. In conclusion, it can be proposed that PET has potential as a noninvasive tool for assessing the expression of steroid receptors in the brain, provided tracers become available that can penetrate the bloodbrain barrier and have higher affinity and metabolic stability.
| PET IMAGING OF AROMATASE AS A BIOMARKER FOR OESTROGEN SYNTHESIS
Aromatase is a key enzyme in the biosynthesis of oestrogens; it catalyses the conversion of testosterone into oestradiol. 71 Aromatase is expressed in a wide variety of tissues, including ovaries, adipose tissue, skin, testicles, muscle, liver and the central nervous system.
Aromatase has been suggested as a biomarker for neuroprotection because it increases the local levels of oestrogens in injured neurones in the brain. 72 Aromatase is not expressed constitutively in the brain but can be induced by testosterone or dihydrotestosterone. 73 Brain aromatase is involved in, amongst others, the regulation of sexual behaviour, emotional behaviour, aggression, cognition, memory and 
| USE OF PET TRACERS TO STUDY SEX STEROID HORMONE-INDUCED CHANGES IN BRAIN FUNCTION
PET imaging using radioligands of receptors related to sex steroid hormone signalling may provide valuable information about the interaction of these hormones with other signalling systems in the brain, as well as the possible behavioural outcome of that interaction, thus offering a wide range of possible studies. PET imaging may also be used to study the impact of steroid hormones on physiological or metabolic biomarkers. Below, we discuss some studies in which the downstream effects of hormonal changes were evaluated by PET imaging.
| Impact of sex steroid hormones in cerebral blood flow
A general approach for studying the impact of steroid hormones is to detect activation of specific brain regions by measurement of the regional cerebral blood flow (rCBF). Changes in cerebral blood flow can be detected with PET using the tracer [ Few preclinical studies using [ The study showed metabolic differences between male monkeys confronted with threats to their exclusive sexual access to a female mate and controls. The differences in brain glucose metabolism were correlated with differences in testosterone levels. 89 [
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F]FDG PET
studies in a rat model of traumatic brain injury aimed to visualise the effects of hormone therapy, using either synthetic or endogenous oestrogens. 90, 91 These studies demonstrated that the steroid hormones reduced the trauma-induced decrease in glucose metabolism, suggesting a beneficial effect on cellular survival. PET study in men with hypogonadism investigated the effect of testosterone substitution therapy on brain glucose metabolism during a mental rotation test. 94 In 4 out of 6 subjects, testosterone substitution improved the mental rotation score and only these subjects showed an increase in [ inferior frontal gyrus, right middle temporal gyrus, left primary visual cortex), which makes it difficult to draw any conclusions.
F I G U R E 3
Besides the investigation of regional glucose metabolism, it is possible to study the connectivity and network changes associated with steroid hormone treatment using [ When pre-and postmenopausal subjects were compared, changes in the amygdala-cortical network connectivity were observed as well.
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F]FDG PET can also be used to study secondary effects associated to hormonal therapies. [ Figure 4 .
| Sex steroid hormones and neurotransmitter activity regulation
Sex steroid hormones are known to participate in many developmental and regulatory processes in the brain. Most of these effects are mediated by either direct actions on hormone receptors or by indirect modulation of other neurotransmitter systems.
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Serotonin is an important neurotransmitter that plays a central role in brain development, stress reactivity, mood and several psychiatric disorders. 104 Serotonin signalling can be affected by sex steroid hormones. 103 Serotonin receptors ( Sex hormone levels were found to be correlated with test scores for aggression and 5-HTR 1A tracer uptake in frontal areas. 108 Serotonin changes have also been studied in the brain of menopausal women treated with hormone therapy, but no significant differences in [ FE-β-CIT, changes in the density of D1 receptors were assessed with Interactions of steroid hormones with the GABAergic neurotansmitter systems have been studied using PET with [ 
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The aforementioned studies show that sex steroid hormones can have an effect on brain neurotransmitter systems and also that these effects can be monitored non-invasively with PET. So far, only few publication describe the use of this approach in neuroendocrinology studies,
indicating an area of research that still remains unexplored. Most of the studies showed interactions of sex hormones with major neurotransmitter systems involved in psychiatric disorders such as serotonin and dopamine, positioning them as likely targets for future research in this field.
| CONCLUSIONS
There is ongoing research on the influence of sex steroid hormones on brain development and brain function. Although the expression of sex steroid hormone receptors in the brain has been demonstrated 9 and some roles of these hormones in the brain have been elucidated, [2] [3] [4] there is still a large gap in our knowledge of these hormone system.
This can be partly be ascribed to the lack of suitable techniques avail- PET imaging can also be used to quantify the effects of sex steroids on brain perfusion and metabolism. Hormone treatment in conditions such as menopause, hypogonadism and steroid abuse appears to provide useful paradigms for studying the effect of steroid signalling on brain activity or examining the relationship between stress hormone levels and biological outcomes in humans. Studies of the correlations between hormone levels in plasma and regional tracer uptake may also provide useful information on the involvement of specific brain regions and regional connectivity. The use of animal models may also be useful because many experimental manipulations can be applied in animals but not in humans.
Furthermore, a plethora of PET tracers for specific neurotransmitter receptors and transporters are available. These tracers enable the investigation of the interaction between sex steroid hormones and various neurotransmitter systems. These studies could help to unravel the mechanisms that are responsible for the impact of sex steroid hormones on brain function and neuroprotection. An improved understanding of these effects could result in the improvement of existing hormone therapies. Studies could focus on, for example, discrimination of specific receptor functions in terms of fast and slow effects, sex differences and the mechanisms of action of steroids in diseases of the brain. We have reviewed PET studies related to the function of sex hormones in the brain. If the limitations identified can be overcome, PET may prove to be a promising non-invasive technique that can be applied in both experimental animals and human subjects, which would facilitate the translation of interesting findings from studies in experimental animals into clinical trials in humans.
